top of page
it's where dermatology lives
![DERM. CITY 2 copy.png](https://static.wixstatic.com/media/cabd8d_a4e332a5f50840f6a64e29150b052324~mv2.png/v1/fill/w_243,h_243,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/DERM_%20CITY%202%20copy.png)
![](https://static.wixstatic.com/media/cabd8d_55924863c38f44ad879b56d5624c813f~mv2.jpg/v1/fill/w_250,h_250,fp_0.50_0.50,q_30,blur_30,enc_auto/cabd8d_55924863c38f44ad879b56d5624c813f~mv2.webp)
![New technology could aid in development of less-painful subcutaneous biologic administration](https://static.wixstatic.com/media/cabd8d_55924863c38f44ad879b56d5624c813f~mv2.jpg/v1/fill/w_440,h_330,fp_0.50_0.50,q_90,enc_auto/cabd8d_55924863c38f44ad879b56d5624c813f~mv2.webp)
By John Evans
Jan 17, 20202 min read
New technology could aid in development of less-painful subcutaneous biologic administration
“We created the platform to provide new information to drug makers to help them better understand the amount of pain a certain injectable me
By John Evans
Jan 10, 20202 min read
Nrp1 a potential new target for psoriasis Tx
“These data demonstrate the therapeutic benefit of blocking Vegfa/Nrp1 interaction in the treatment of psoriatic disease, which may be safer
![](https://static.wixstatic.com/media/cabd8d_bc2c8d455dca4674be6646a473e9dc7a~mv2_d_4272_2848_s_4_2.jpg/v1/fill/w_250,h_250,fp_0.50_0.50,q_30,blur_30,enc_auto/cabd8d_bc2c8d455dca4674be6646a473e9dc7a~mv2_d_4272_2848_s_4_2.webp)
![More effective rituximab dosing for pemphigus identified](https://static.wixstatic.com/media/cabd8d_bc2c8d455dca4674be6646a473e9dc7a~mv2_d_4272_2848_s_4_2.jpg/v1/fill/w_440,h_330,fp_0.50_0.50,q_90,enc_auto/cabd8d_bc2c8d455dca4674be6646a473e9dc7a~mv2_d_4272_2848_s_4_2.webp)
By John Evans
Nov 15, 20192 min read
More effective rituximab dosing for pemphigus identified
“This is the first study to provide evidence for physicians to justify a lymphoma-dose regimen of rituximab when treating their patients wit
![](https://img.youtube.com/vi/Z4lOCTR1QA0/mqdefault.jpg)
![Largest of Its Kind Study Examines Safety of Systemic Treatments for Patients With Psoriasis](https://img.youtube.com/vi/Z4lOCTR1QA0/mqdefault.jpg)
by Cory Perla
May 16, 20191 min read
Largest of Its Kind Study Examines Safety of Systemic Treatments for Patients With Psoriasis
A large new study has evaluated the risk of infection associated with various biologic therapies for patients with psoriasis finding that th
Featured Posts
![Nominations for the 2024 Women in Dermatology Honour Roll closing soon](https://static.wixstatic.com/media/cabd8d_0fdc657314ef43c68e19c8cdf46db6c8~mv2.webp)
![](https://static.wixstatic.com/media/11062b_dcaf27922fcb42e0b5a8a951f36f36b4~mv2.jpeg/v1/fill/w_250,h_250,fp_0.50_0.50,q_30,blur_30,enc_auto/11062b_dcaf27922fcb42e0b5a8a951f36f36b4~mv2.webp)
![Invitation to participate: Skin of Colour nomenclature survey study](https://static.wixstatic.com/media/11062b_dcaf27922fcb42e0b5a8a951f36f36b4~mv2.jpeg/v1/fill/w_329,h_247,fp_0.50_0.50,q_90,enc_auto/11062b_dcaf27922fcb42e0b5a8a951f36f36b4~mv2.webp)
bottom of page